Treating rheumatic diseases in pregnancy: dos and don'ts. Review uri icon

Overview

abstract

  • This paper presents a critical appraisal of the current evidence and recommendations regarding the use of pharmaceuticals and biologicals in pregnancy. Clinical experience is often at variance with published recommendations as studies have not taken into account the differences in physiology in the various stages of gestation and between animal and human pregnancies. Physicians should bear in mind that pregnancy causes disruption in several organ systems; the effects of an intervention may depend on the stage of gestation; and some effects of interventions in pregnancy may not manifest until adulthood.

publication date

  • November 1, 2006

Research

keywords

  • Antirheumatic Agents
  • Pregnancy Complications
  • Rheumatic Diseases

Identity

PubMed Central ID

  • PMC1798378

Scopus Document Identifier

  • 33750296915

Digital Object Identifier (DOI)

  • 10.1136/ard.2006.058420

PubMed ID

  • 17038475

Additional Document Info

volume

  • 65 Suppl 3

issue

  • Suppl 3